Objectives: To establish and estimate an enzymatic measurement of crea
tine in erythrocytes as an index of the erythrocyte lire time. Design
and Method: The measurement of creatine in erythrocytes was performed
using an enzymatic assay kit that was developed for serum and urine cr
eatine. An erythrocyte sample was subjected to creatine measurement af
ter hemolysis and deproteinization. Performance of the method for crea
tine measurement in erythrocytes was estimated. Effects of age and gen
der on the creatine content of erythrocytes were also estimated in 305
normal subjects. Results: The method showed within-run CVs varying fr
om 0.7 to 1.0% (n = 20), and between-day CVs from 1.3 to 1.7% (15 days
). Good linearity was observed at least up to 1000 mu mol/L as creatin
e value in hemolyzed sample. The analytical recovery was calculated to
be 98.1 +/- 1.3% on average. No considerable interference by various
substances, including guanidino compounds and amino acids, with the as
say was observed. Excellent correlation was observed between the prese
nt method and high performance liquid chromatography. With the unit of
mu mol/g Hb: slope, 1.034 +/- 0.003 (mean +/- SD); intercept. -0.059
+/- 0.012 (mean +/- SD); correlation coefficient, 0.9996; and Sy.x, 0.
069. With the unit of mu mol/L RBC: slope, 1.033 +/- 0.003 (mean +/- S
D); intercept, -18.23 +/- 3.55 (mean +/- SD); correlation coefficient,
0.9996; and Sy.x, 20.40. A significant increase in erythrocyte creati
ne was observed in females aged 11- to 50 years old as compared with m
ales in the corresponding age bracket, however, a gender difference wa
s not observed in other age bracket. This finding suggests the possibi
lity of a slight decrease in the erythrocyte life time due to menstrua
tion in females. Conclusion: This study showed that the present method
is favorable for quantifying erythrocyte creatine, and has analytical
characteristics suitable for routine work in clinical laboratories. C
opyright (C) 1998 The Canadian Society of Clinical Chemists.